MOTS-c 5 mg Certificate of Analysis Batch APL-MOTS5-2609-04

MOTS-c 5 mg from batch APL-MOTS5-2609-04 was analysed on 19 September 2026 and measured 98.87% purity by HPLC / Mass Spectrometry, passing all 5 release tests.

Purity: 98.87%
Result: All 5 tests passed
Tested: 19 September 2026
Method: HPLC / Mass Spectrometry
Net content: 5.06 mg

Independent verification

MOTS-c 5 mg is independently verified by Ozcanium Analytics, an independent Australian laboratory, at 98.59% purity by UPLC-MS/MS, analysed 29 August 2026 on lot APL-MOTS10-2608-01, net content 9.80 mg, verification code OZ-HPLCMS-TS08; bacterial endotoxin below 15.0 EU per vial by kinetic chromogenic LAL, analysed 30 August 2026, verification code OZ-ENDOTX-TAU5.

Issued by Ozcanium Analytics. Covers every vial size of this compound; each report opens as the laboratory issued it.

Third-Party Purity COA (PDF, opens in a new tab)98.59% purity by UPLC-MS/MS · net content 9.80 mg Analysed 29 August 2026 Verification code OZ-HPLCMS-TS08
Third-Party Endotoxin Test (PDF, opens in a new tab)Bacterial endotoxin below 15.0 EU per vial by kinetic chromogenic LAL Analysed 30 August 2026 Verification code OZ-ENDOTX-TAU5

Enter a code in the Ozcanium Analytics verification portal (opens in a new tab) to confirm the report against their own records.

The certificate as issued is reproduced below — pinch to zoom on a phone, or use Print / Save as PDF for a full-size copy.

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 1 of 2

Certificate of Analysis MOTS-c 5 mg Batch APL-MOTS5-2609-04

Compound: MOTS-c
Lot Number: APL-MOTS5-2609-04
Analysis Date: 19 September 2026
Method: HPLC / Mass Spectrometry
Purity: 98.87%
Net Content: 5.06 mg

CAS Number: 1627580-64-6
Formula: C101H152N28O22S2
Molecular Weight: 2174.6 g/mol
Form: Lyophilised Powder
Manufactured: September 2026
Issued: 19 September 2026
Document ID: APL-COA-MOTS5-2609-04
Verification Code: Batch traceable

SequenceMRWQEMGYIFYPRKLR

High Performance Liquid Chromatography (HPLC-UV) Chromatogram

Main peak integrated at 98.87% of total area; no single impurity peak exceeds 0.51%.

Peak List

Peaks detected: 5

#	Time (min)	Area	% Area	Identification
1	4.280	19,859	0.286	—
2	4.483	35,552	0.512	—
3	4.628	6,865,382	98.870	MOTS-c
4	5.120	15,901	0.229	—
5	6.184	7,152	0.103	—

Analytical Results

Test	Specification	Result	Status
Appearance	White/Off-White Lyophilised Powder	Conforms	PASS
Identity (MS)	Confirmed	Confirmed	PASS
Purity (HPLC)	≥98.0%	98.87%	PASS
Peptide Content	95–105%	98.8%	PASS
Endotoxins	<0.5 EU/mg	<0.25 EU/mg	PASS

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 2 of 2

MOTS-c 5 mg

CAS Number: 1627580-64-6

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 19 September 2026

Monitored (m/z)	Detected (m/z)	Relative Intensity
545	545.34	0.94
726	726.48	2.97
1088	1088.29	1.41

Detection assignment: MOTS-c

Collected Mass Spectrum

Intensity ×10⁷

Verification Protocol

Identity confirmed by mass spectrometry against the expected ion channels.
Purity measured by HPLC as peak area against all integrated impurity peaks.
Batch traceability: this document reports the lot number printed on the vial.
Analysis performed in-house by Australian Peptide Labs.

Supplied for laboratory research use only. Not a therapeutic good; not for human or veterinary use.

View MOTS-c in the catalogue How to read this certificate